Deleterious CNS effects of the APOE epsilon4 allele in individuals with HIV-1 infection may be age-dependent

Comment

Nunzio Pomara et al. Proc Natl Acad Sci U S A. 2008.

. 2008 Oct 14;105(41):E65; author reply E67-8.

doi: 10.1073/pnas.0806356105. Epub 2008 Oct 8.

No abstract available

Conflict of interest statement

The authors declare no conflict of interest.

Apolipoprotein (apo) E4 enhances HIV-1 cell entry in vitro, and the APOE epsilon4/epsilon4 genotype accelerates HIV disease progression.
Burt TD, Agan BK, Marconi VC, He W, Kulkarni H, Mold JE, Cavrois M, Huang Y, Mahley RW, Dolan MJ, McCune JM, Ahuja SK. Burt TD, et al. Proc Natl Acad Sci U S A. 2008 Jun 24;105(25):8718-23. doi: 10.1073/pnas.0803526105. Epub 2008 Jun 18. Proc Natl Acad Sci U S A. 2008. PMID: 18562290 Free PMC article.

1. Burt TD, et al. Apolipoprotein (apo) E4 enhances HIV-1 cell entry in vitro, and the APOE ε4/ε4 genotype accelerates HIV disease progression. Proc Natl Acad Sci USA. 2008;105:8718–8723. - PMC - PubMed
1. Pomara N, Belzer KD, Silva R, Cooper TB, Sidtis JJ. The apolipoprotein E ε4 allele and memory performance in HIV-1 seropositive subjects: Differences at baseline but not after acute oral lorazepam challenge. Psychopharmacology. 2008 Jul 31; epub ahead of print. - PubMed
1. Corder E, et al. HIV-infected subjects with the E4 allele for APOE have excess dementia and peripheral neuropathy. Nat Med. 1998;4:1182–1184. - PubMed
1. Dunlop O, et al. HIV dementia and apolipoprotein E. Acta Neurol Scand. 1997;95:315–318. - PubMed
1. Valcour V, et al. Age, apolipoprotein E4, and the risk of HIV dementia: The Hawaii Aging with HIV Cohort. J Neuroimmunol. 2004;157:197–202. - PubMed